Working… Menu
Trial record 9 of 17 for:    Necrotizing Fascitis

Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections (ACCUTE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02469857
Recruitment Status : Active, not recruiting
First Posted : June 12, 2015
Last Update Posted : August 6, 2019
Biomedical Advanced Research and Development Authority
Information provided by (Responsible Party):
Atox Bio Ltd

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 2019
Estimated Study Completion Date : November 2019